| Ident. | Authors (with country if any) | Title |
|---|
| 000224 (2017) |
Julianne Bayliss ; Lilly Yuen ; Gillian Rosenberg ; Darren Wong ; Margaret Littlejohn ; Kathleen Jackson ; Anuj Gaggar ; Kathryn M. Kitrinos ; G Mani Subramanian ; Patrick Marcellin ; Maria Buti ; Harry L A. Janssen ; Ed Gane ; Vitina Sozzi ; Danni Colledge ; Rachel Hammond ; Rosalind Edwards ; Stephen Locarnini ; Alexander Thompson ; Peter A. Revill | Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B. |
| 000912 (2017) |
Ira M. Jacobson ; Eric Lawitz ; Edward J. Gane ; Bernard E. Willems ; Peter J. Ruane ; Ronald G. Nahass ; Sergio M. Borgia ; Stephen D. Shafran ; Kimberly A. Workowski ; Brian Pearlman ; Robert H. Hyland ; Luisa M. Stamm ; Evguenia Svarovskaia ; Hadas Dvory-Sobol ; Yanni Zhu ; G Mani Subramanian ; Diana M. Brainard ; John G. Mchutchison ; Norbert Br U ; Thomas Berg ; Kosh Agarwal ; Bal Raj Bhandari ; Mitchell Davis ; Jordan J. Feld ; Gregory J. Dore ; Catherine A M. Stedman ; Alexander J. Thompson ; Tarik Asselah ; Stuart K. Roberts ; Graham R. Foster | Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials. |
| 000A38 (2017) |
Marc Bourlière ; Stuart C. Gordon ; Steven L. Flamm ; Curtis L. Cooper ; Alnoor Ramji ; Myron Tong ; Natarajan Ravendhran ; John M. Vierling ; Tram T. Tran ; Stephen Pianko ; Meena B. Bansal ; Victor De Lédinghen ; Robert H. Hyland ; Luisa M. Stamm ; Hadas Dvory-Sobol ; Evguenia Svarovskaia ; Jie Zhang ; K C Huang ; G Mani Subramanian ; Diana M. Brainard ; John G. Mchutchison ; Elizabeth C. Verna ; Peter Buggisch ; Charles S. Landis ; Ziad H. Younes ; Michael P. Curry ; Simone I. Strasser ; Eugene R. Schiff ; K Rajender Reddy ; Michael P. Manns ; Kris V. Kowdley ; Stefan Zeuzem | Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. |
| 001019 (2017) |
Mark S. Sulkowski ; Walford J. Fessel ; Adriano Lazzarin ; Juan Berenguer ; Natalia Zakharova ; Hugo Cheinquer ; Pierre Côté ; Douglas Dieterich ; Adrian Gadano ; Gail Matthews ; Jean-Michel Molina ; Christophe Moreno ; Juan Antonio Pineda ; Federico Pulido ; Antonio Rivero ; Jurgen Rockstroh ; Dennis Hernandez ; Fiona Mcphee ; Timothy Eley ; Zhaohui Liu ; Patricia Mendez ; Eric Hughes ; Stephanie Noviello ; Peter Ackerman | Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study. |
| 001457 (2016) |
Jason Grebely ; Stefan Mauss ; Ashley Brown ; Jean-Pierre Bronowicki ; Massimo Puoti ; David Wyles ; Macky Natha ; Yanni Zhu ; Junming Yang ; Bruce Kreter ; Diana M. Brainard ; Chohee Yun ; Val Carr ; Gregory J. Dore | Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials. |
| 001689 (2016) |
P. Marcellin ; S H Ahn ; W-L Chuang ; A J Hui ; F. Tabak ; R. Mehta ; J. Petersen ; C-M Lee ; X. Ma ; F A Caruntu ; W Y Tak ; M. Elkhashab ; L. Lin ; G. Wu ; E B Martins ; P. Charuworn ; L J Yee ; S G Lim ; G R Foster ; S. Fung ; L. Morano ; D. Samuel ; K. Agarwal ; R. Idilman ; S I Strasser ; M. Buti ; G B Gaeta ; G. Papatheodoridis ; R. Flisiak ; H L Y. Chan | Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B. |
| 001974 (2016) |
Cécile H. Herbreteau ; Mélanie Denizot ; Suzanne Lowther ; Sarah Riddell ; Leah Frazer ; Jessica Haining ; Rachel Arkinstall ; Jean Payne ; Jenni Harper ; Dayna Johnson ; Anaïs Pasquier ; Deborah Middleton ; Jean-François Saluzzo | Efficacy of a specific polyclonal equine F(ab')2 against avian influenza (H5N1) in ferrets: synergy with oseltamivir. |
| 001E20 (2016) |
Michael Manns ; Didier Samuel ; Edward J. Gane ; David Mutimer ; Geoff Mccaughan ; Maria Buti ; Martín Prieto ; José Luis Calleja ; Markus Peck-Radosavljevic ; Beat Müllhaupt ; Kosh Agarwal ; Peter Angus ; Eric M. Yoshida ; Massimo Colombo ; Mario Rizzetto ; Hadas Dvory-Sobol ; Jill Denning ; Sarah Arterburn ; Phillip S. Pang ; Diana Brainard ; John G. Mchutchison ; Jean-François Dufour ; Hans Van Vlierberghe ; Bart Van Hoek ; Xavier Forns | Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial. |
| 001E90 (2016) |
Vincent Leroy ; Peter Angus ; Jean-Pierre Bronowicki ; Gregory J. Dore ; Christophe Hezode ; Stephen Pianko ; Stanislas Pol ; Katherine Stuart ; Edmund Tse ; Fiona Mcphee ; Rafia Bhore ; Maria Jesus Jimenez-Exposito ; Alexander J. Thompson | Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+). |
| 001E94 (2016) |
A. Velay ; H. Jeulin ; M. Eschlimann ; B. Malvé ; F. Goehringer ; M. Bensenane ; J-P Frippiat ; P. Abraham ; A M Ismail ; J M Murray ; C. Combet ; F. Zoulim ; J-P Bronowicki ; E. Schvoerer | Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy. |
| 001F58 (2016) |
Stella G. Muthuri ; Sudhir Venkatesan ; Puja R. Myles ; Jo Leonardi-Bee ; Wei Shen Lim ; Abdullah Al Mamun ; Ashish P. Anovadiya ; Wildo N. Araújo ; Eduardo Azziz-Baumgartner ; Clarisa Báez ; Carlos Bantar ; Mazen M. Barhoush ; Matteo Bassetti ; Bojana Beovic ; Roland Bingisser ; Isabelle Bonmarin ; Victor H. Borja-Aburto ; Bin Cao ; Jordi Carratala ; María R. Cuezzo ; Justin T. Denholm ; Samuel R. Dominguez ; Pericles A D. Duarte ; Gal Dubnov-Raz ; Marcela Echavarria ; Sergio Fanella ; James Fraser ; Zhancheng Gao ; Patrick Gérardin ; Maddalena Giannella ; Sophie Gubbels ; Jethro Herberg ; Anjarath L. Higuera Iglesias ; Peter H. Hoeger ; Matthias Hoffmann ; Xiaoyun Hu ; Quazi T. Islam ; Mirela F. Jiménez ; Amr Kandeel ; Gerben Keijzers ; Hossein Khalili ; Gulam Khandaker ; Marian Knight ; Gabriela Kusznierz ; Ilija Kuzman ; Arthur M C. Kwan ; Idriss Lahlou Amine ; Eduard Langenegger ; Kamran B. Lankarani ; Yee-Sin Leo ; Rita Linko ; Pei Liu ; Faris Madanat ; Toshie Manabe ; Elga Mayo-Montero ; Allison Mcgeer ; Ziad A. Memish ; Gokhan Metan ; Dragan Miki ; Kristin G I. Mohn ; Ahmadreza Moradi ; Pagbajabyn Nymadawa ; Bulent Ozbay ; Mehpare Ozkan ; Dhruv Parekh ; Mical Paul ; Wolfgang Poeppl ; Fernando P. Polack ; Barbara A. Rath ; Alejandro H. Rodríguez ; Marilda M. Siqueira ; Joanna Skr T-Magierło ; Ewa Talarek ; Julian W. Tang ; Antoni Torres ; Selda H. Törün ; Dat Tran ; Timothy M. Uyeki ; Annelies Van Zwol ; Wendy Vaudry ; Daiva Velyvyte ; Tjasa Vidmar ; Paul Zarogoulidis ; Jonathan S. Nguyen-Van-Tam | Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis. |
| 002057 (2016) |
Peter Revill ; Barbara Testoni ; Stephen Locarnini ; Fabien Zoulim | Global strategies are required to cure and eliminate HBV infection. |
| 002103 (2016) |
Romain Palich ; Jean-Luc Gala ; Frédéric Petitjean ; Susan Shepherd ; Olivier Peyrouset ; Bing M. Abdoul ; Moumouni Kinda ; Christine Danel ; Augustin Augier ; Xavier Anglaret ; Denis Malvy ; Nicole Blackwell | A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea. |
| 002176 (2016) |
Tarik Asselah ; Alex J. Thompson ; Robert Flisiak ; Manuel Romero-Gomez ; Diethelm Messinger ; Georgios Bakalos ; Mitchell L. Shiffman | A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin. |
| 002538 (2016) |
Maria Luisa Montes ; Mark Nelson ; Pierre-Marie Girard ; Joe Sasadeusz ; Andrzej Horban ; Beatriz Grinsztejn ; Natalia Zakharova ; Antonio Rivero ; Jacques Durant ; Enrique Ortega-Gonzalez ; Erkki Lathouwers ; Katrien Janssen ; Sivi Ouwerkerk-Mahadevan ; James Witek ; Juan González-García | Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study. |
| 002592 (2015) |
Tarik Asselah ; Stefan Zeuzem ; Vicente Soriano ; Jean-Pierre Bronowicki ; Ansgar W. Lohse ; Beat Müllhaupt ; Marcus Schuchmann ; Marc Bourlière ; Maria Buti ; Stuart K. Roberts ; Edward J. Gane ; Jerry O. Stern ; Florian Voss ; Patrick Baum ; John-Paul Gallivan ; Wulf O. Böcher ; Federico J. Mensa | ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection. |
| 002603 (2015) |
Graham R. Foster ; Nezam Afdhal ; Stuart K. Roberts ; Norbert Br U ; Edward J. Gane ; Stephen Pianko ; Eric Lawitz ; Alex Thompson ; Mitchell L. Shiffman ; Curtis Cooper ; William J. Towner ; Brian Conway ; Peter Ruane ; Marc Bourlière ; Tarik Asselah ; Thomas Berg ; Stefan Zeuzem ; William Rosenberg ; Kosh Agarwal ; Catherine A M. Stedman ; Hongmei Mo ; Hadas Dvory-Sobol ; Lingling Han ; Jing Wang ; John Mcnally ; Anu Osinusi ; Diana M. Brainard ; John G. Mchutchison ; Francesco Mazzotta ; Tram T. Tran ; Stuart C. Gordon ; Keyur Patel ; Nancy Reau ; Alessandra Mangia ; Mark Sulkowski | Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection. |
| 002684 (2015) |
T Jake Liang ; Timothy M. Block ; Brian J. Mcmahon ; Marc G. Ghany ; Stephan Urban ; Ju-Tao Guo ; Stephen Locarnini ; Fabien Zoulim ; Kyong-Mi Chang ; Anna S. Lok | Present and future therapies of hepatitis B: From discovery to cure. |
| 002795 (2015) |
D. Wolfe ; N. Luhmann ; M. Harris ; A. Momenghalibaf ; E. Albers ; J. Byrne ; T. Swan | Human rights and access to hepatitis C treatment for people who inject drugs. |
| 002A81 (2015) |
Jürgen K. Rockstroh ; Mark Nelson ; Christine Katlama ; Jay Lalezari ; Josep Mallolas ; Mark Bloch ; Gail V. Matthews ; Michael S. Saag ; Philippe J. Zamor ; Chloe Orkin ; Jacqueline Gress ; Stephanie Klopfer ; Melissa Shaughnessy ; Janice Wahl ; Bach-Yen T. Nguyen ; Eliav Barr ; Heather L. Platt ; Michael N. Robertson ; Mark Sulkowski | Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial. |
| 002C31 (2015) |
Dorothée Obach ; Yazdan Yazdanpanah ; Gamal Esmat ; Anchalee Avihingsanon ; Sahar Dewedar ; Nicolas Durier ; Alain Attia ; Wagida A. Anwar ; Anthony Cousien ; Pisit Tangkijvanich ; Serge Paul Eholié ; Wahid Doss ; Aya Mostafa ; Arnaud Fontanet ; Mostafa K. Mohamed ; Sylvie Deuffic-Burban | How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries. |
